1. Home
  2. RGEN vs MTCH Comparison

RGEN vs MTCH Comparison

Compare RGEN & MTCH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RGEN
  • MTCH
  • Stock Information
  • Founded
  • RGEN 1981
  • MTCH 1986
  • Country
  • RGEN United States
  • MTCH United States
  • Employees
  • RGEN N/A
  • MTCH N/A
  • Industry
  • RGEN Medical/Dental Instruments
  • MTCH Computer Software: Programming Data Processing
  • Sector
  • RGEN Health Care
  • MTCH Technology
  • Exchange
  • RGEN Nasdaq
  • MTCH Nasdaq
  • Market Cap
  • RGEN 8.2B
  • MTCH 9.2B
  • IPO Year
  • RGEN N/A
  • MTCH 2015
  • Fundamental
  • Price
  • RGEN $136.22
  • MTCH $36.03
  • Analyst Decision
  • RGEN Buy
  • MTCH Buy
  • Analyst Count
  • RGEN 10
  • MTCH 20
  • Target Price
  • RGEN $188.38
  • MTCH $43.22
  • AVG Volume (30 Days)
  • RGEN 772.8K
  • MTCH 3.8M
  • Earning Date
  • RGEN 10-29-2024
  • MTCH 10-29-2024
  • Dividend Yield
  • RGEN N/A
  • MTCH N/A
  • EPS Growth
  • RGEN N/A
  • MTCH 41.22
  • EPS
  • RGEN N/A
  • MTCH 2.31
  • Revenue
  • RGEN $602,354,000.00
  • MTCH $3,471,541,000.00
  • Revenue This Year
  • RGEN $0.08
  • MTCH $7.09
  • Revenue Next Year
  • RGEN $12.97
  • MTCH $6.52
  • P/E Ratio
  • RGEN N/A
  • MTCH $15.54
  • Revenue Growth
  • RGEN N/A
  • MTCH 8.07
  • 52 Week Low
  • RGEN $110.45
  • MTCH $27.66
  • 52 Week High
  • RGEN $211.13
  • MTCH $42.87
  • Technical
  • Relative Strength Index (RSI)
  • RGEN 37.10
  • MTCH 52.45
  • Support Level
  • RGEN $138.80
  • MTCH $34.88
  • Resistance Level
  • RGEN $150.72
  • MTCH $35.92
  • Average True Range (ATR)
  • RGEN 5.27
  • MTCH 0.92
  • MACD
  • RGEN -1.23
  • MTCH -0.24
  • Stochastic Oscillator
  • RGEN 1.94
  • MTCH 43.55

About RGEN Repligen Corporation

Repligen Corp is a global life sciences company. It develops and commercializes innovative bioprocessing technologies and systems that increase efficiencies and flexibility in the process of manufacturing biological drugs. The company's customers include life science companies, global biopharmaceutical companies, and contract manufacturers worldwide. Repligen markets its products globally through a direct commercial organization in the U.S., Europe, and Asia, as well as through strategic partners in select markets. The majority of the company's revenue is generated in North America.

About MTCH Match Group Inc.

Match Group is a provider of online dating products. The firm became public in 2015 and was more than 80% owned by IAC/InterActiveCorp until IAC spun it off in 2020. The company has a vast portfolio of different online dating service providers, including Tinder, Hinge, BLK, Chispa, Match.com, OkCupid, PlentyOfFish, and Meetic. Match Group has more than 45 brands of online dating sites and/or apps, from which it generates user fee revenue (95%) and advertising revenue (5%).

Share on Social Networks: